Scaffold Hopping Strategy to Identify Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy-Reference-Cited by-同舟云学术

Scaffold Hopping Strategy to Identify Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy

Published:2022-05-31 Issue:11 Volume:65 Page:7896-7917
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wang Wei¹^ORCID,He Jiacheng¹,Yang Junjie¹^ORCID,Zhang Chan¹,Cheng Zhiyuan¹^ORCID,Zhang Yao¹,Zhang Qiansen¹^ORCID,Wang Peili¹^ORCID,Tang Shuowen¹,Wang Xin¹,Liu Mingyao¹^ORCID,Lu Weiqiang¹^ORCID,Zhang Han-Kun¹^ORCID

Affiliation:

1. Drug Discovery Unit, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00448

Reference66 articles.

1. Harnessing innate immunity in cancer therapy

2. The influence of microenvironment on tumor immunotherapy